E-LIB Suche - Ergebnisse für: Factor, Rachel E.

1

A color‐based tumor segmentation method for clinical ex viv..:

Wang, Roujia ; Ekem, Lillian ; Gallagher, Jennifer...
Journal of Biophotonics. 17 (2024) 5 - p. , 2024

Link: https://doi.org/10.1002/..

2

After neoadjuvant therapy, axillary sentinel lymph node fro..:

McMurtry, Valarie ; Poretta, Jane M. ; Factor, Rachel E.
Journal of Pathology Informatics. 13 (2022) - p. 100092 , 2022

Link: https://doi.org/10.1016/..

3

A human breast cancer-derived xenograft and organoid platfo..:

Guillen, Katrin P. ; Fujita, Maihi ; Butterfield, Andrew J....
Nature Cancer. 3 (2022) 2 - p. 232-250 , 2022

Link: https://doi.org/10.1038/..

4

Novel temporal and spatial patterns of metastatic colonizat..:

Huang, Xiaomeng ; Qiao, Yi ; Brady, Samuel W....
Genome Medicine. 13 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

5

Histology to 3D in vivo MR registration for volumetric eval..:

Zimmerman, Blake E. ; Johnson, Sara L. ; Odéen, Henrik A....
Scientific Reports. 11 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

6

Spatially-resolved quantification of proteins in triple neg..:

Stewart, Rachel L. ; Matynia, Anna P. ; Factor, Rachel E..
Scientific Reports. 10 (2020) 1 - p. , 2020

Link: https://doi.org/10.1038/..

7

The FDA-Approved Breast Cancer HER2 Evaluation Kit (HercepT..:

Schneider, Frank ; Jin, Yulan ; Van Smaalen, Kevin...
American Journal of Clinical Pathology. 151 (2019) 5 - p. 504-510 , 2019

Link: https://doi.org/10.1093/..

8

Differences in molecular features of triple‐negative breast..:

Gulbahce, H. Evin ; Bernard, Philip S. ; Weltzien, Erin K....
Cancer. 124 (2018) 24 - p. 4676-4684 , 2018

Link: https://doi.org/10.1002/..

9

Publisher Correction: Combating subclonal evolution of resi..:

Brady, Samuel W. ; McQuerry, Jasmine A. ; Qiao, Yi...
Nature Communications. 9 (2018) 1 - p. , 2018

Link: https://doi.org/10.1038/..

10

What Does it Mean for a Recommendation to be Evidence-Based:

Schmidt, Robert L ; Factor, Rachel E
Laboratory Medicine. 50 (2018) 1 - p. 5-7 , 2018

Link: https://doi.org/10.1093/..

11

POWERPIINC (PreOperative Window of Endocrine TheRapy Provid..:

Cohen, Adam L. ; Factor, Rachel E. ; Mooney, Kathi...
The Breast. 31 (2017) - p. 219-223 , 2017

Link: https://doi.org/10.1016/..

12

HER2 immunohistochemical and fluorescence in situ hybridiza..:

Stewart, Rachel L ; Caron, Justin E ; Gulbahce, Evin H...
Modern Pathology. 30 (2017) 11 - p. 1561-1566 , 2017

Link: https://doi.org/10.1038/..

13

Combating subclonal evolution of resistant cancer phenotype:

Brady, Samuel W. ; McQuerry, Jasmine A. ; Qiao, Yi...
Nature Communications. 8 (2017) 1 - p. , 2017

Link: https://doi.org/10.1038/..

14

The molecular basis of breast cancer pathological phenotype:

Heng, Yujing J ; Lester, Susan C ; Tse, Gary MK...
The Journal of Pathology. 241 (2016) 3 - p. 375-391 , 2016

Link: https://doi.org/10.1002/..

15

Researchers should be aware of partial verification bias in..:

Schmidt, Robert L. ; Factor, Rachel E.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 119 (2015) 5 - p. 593 , 2015

Link: https://doi.org/10.1016/..